International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral Drug Association (PDA), has announced the winners for the INTERPHEX Exhibitor Awards for 2016.

Nemera was recognized for the ‘Best New Product’ for Novelia® BFS, its preservative-free multi-dose eyedropper combined with bottlepack® technology.

Novelia® works with high viscosity suspensions and solutions of up to 1500 cps and limits the distribution of liquids to one drop at a time. The doses of the drops are precise, which assist medication adherence.

Nemera and Rommelag combined their advanced technologies and experiences to create a preservative-free multidose ophthalmic dropper processed by Blow-Fill-Seal (BFS).

Key benefits of Novelia®

• 100% controlled and safe thanks to its patented PureFlowTM Technology
• Works with high viscosity suspensions and solutions up to 1500cps
• User-friendly and intuitive: easy eye targeting thanks to its blue tip feature, as easy to use as any standard eyedropper
• One drop at a time into the patient’s eye
• Calibrated drops providing a precise dose for a better treatment adherence 

Key benefits of BFS

• Advanced aseptic BFS process according to US Pharmacopeia, FDA and GMP Guidelines
• Highest sterility assurance with BFS Technology
• Proven and cost-effective production
• Customized container designs for differentiated products
• Ergonomic and easy to squeeze bottles

Nemera’s Novelia® BFS was presented at the INTERPHEX opening ceremony, on Tuesday, April 26th. The convention is currently taking place at The Javits Center, New York City, until Thursday 28th April.

To learn more about this technology, visit booth 1636.

For further information or to arrange a meeting with a member of the executive team during the show, please contact Juan Sarmiento at [email protected]